Edition:
United States

Ocular Therapeutix Inc (OCUL.OQ)

OCUL.OQ on NASDAQ Stock Exchange Global Market

6.63USD
23 May 2018
Change (% chg)

$-0.19 (-2.79%)
Prev Close
$6.82
Open
$6.82
Day's High
$6.89
Day's Low
$6.55
Volume
89,362
Avg. Vol
117,323
52-wk High
$11.79
52-wk Low
$3.30

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.39 December 25 May 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 4 4 4
(3) HOLD 0 0 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.60 1.67 1.86 1.86

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 5 0.35 0.64 0.20 10.97
Quarter Ending Sep-18 5 0.41 0.73 0.30 14.31
Year Ending Dec-18 5 1.52 2.53 1.10 34.68
Year Ending Dec-19 4 25.87 33.49 17.00 96.68
Earnings (per share)
Quarter Ending Jun-18 5 -0.39 -0.36 -0.43 -0.40
Quarter Ending Sep-18 5 -0.40 -0.35 -0.43 -0.33
Year Ending Dec-18 5 -1.58 -1.43 -1.75 -1.77
Year Ending Dec-19 4 -1.29 -0.77 -1.73 -0.30

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.45 0.34 0.11 24.75
Quarter Ending Dec-17 0.52 0.49 0.04 6.95
Quarter Ending Sep-17 0.51 0.52 0.01 2.35
Quarter Ending Jun-17 0.49 0.44 0.05 10.02
Quarter Ending Mar-17 0.47 0.47 0.00 0.15

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.35 0.35 0.49 0.49 10.97
Quarter Ending Sep-18 0.41 0.41 0.55 0.55 14.31
Year Ending Dec-18 1.52 1.52 2.03 2.03 34.68
Year Ending Dec-19 25.87 25.87 32.13 29.82 96.68

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 3
Quarter Ending Sep-18 0 0 0 3
Year Ending Dec-18 0 0 1 4
Year Ending Dec-19 0 0 0 1
Earnings